Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary In-Stent Restenosis
Flavio Airoldi(Vita-Salute San Raffaele University), Antonio Colombo(Humanitas University), Matteo Montorfano(San Raffaele University of Rome), Iassen Michev(Vita-Salute San Raffaele University), John Cosgrave(EMO GVM Centro Cuore Columbus), Renata Rogacka, Giuseppe Sangiorgi(University of Rome Tor Vergata), Ιoannis Iakovou(Vita-Salute San Raffaele University), Carlo Briguori, Giuseppe Biondi‐Zoccai(Maria Cecilia Hospital), Mauro Carlino(San Raffaele University of Rome), Goran Stanković(University of Belgrade), Alaide Chieffo
Cited by 28
Related Papers
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
|PubMed|2005|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k